Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Clinican is a standardized medicinal cannabis extract developed through research by Wageningen Research Stichting (Wageningen University & Research). It is formulated as a cannabis-based medicinal product (CBMP) containing specific ratios of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). The product is primarily investigated for its efficacy in treating symptoms associated with multiple sclerosis, such as spasticity and pain, as well as for the management of insomnia. Clinican works by interacting with the body's endocannabinoid system, specifically acting as an agonist at the CB1 and CB2 receptors, which are involved in pain modulation, motor control, and sleep regulation. The development of Clinican focuses on providing a high-quality, standardized alternative to non-standardized cannabis products to ensure consistent therapeutic outcomes and patient safety.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Clinican.